Skip to main content
Premium Trial:

Request an Annual Quote

XDx Gets $12.5M Loan Facility from GE Capital

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – XDx today said that it has established a $12.5 million senior secured loan facility with GE Capital, Healthcare Financial Services.

The Brisbane, Calif.-based molecular diagnostics firm said that it would use the funds as working capital to support expanded commercialization of its AlloMap multi-gene molecular expression tests.

The company received US Food and Drug Administration clearance in 2008 its AlloMap test for heart transplant patients. Today, it said that it plans to pursue development of other gene expression-based tests for autoimmune diseases including lupus.

"This facility together with our other financial resources and existing cash should allow us to execute our growth strategy focused on commercializing and further developing our proprietary molecular diagnostics technology," Jean-Frederic Viret, CFO of privately held XDx said in a statement.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more